Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Monoclonal Antibody

News   Feb 10, 2010

 
Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Monoclonal Antibody
 
 
 

RELATED ARTICLES

SCIEX Receive Science and Technology Award at HUPO 2017

News

Two researchers from SCIEX received the HUPO 2017 award at the 16th Human Proteome Organization World Congress in Dublin, Ireland.

READ MORE

Machine Learning to Increase the Pace of Brain Imaging Analysis

News

New approach could allow doctors or researchers to quickly identify the data they need, and then rapidly fill in the fine details, making the process faster and more accurate.

READ MORE

Drug Discovery Alliance Formed to Help Increase Drug Development Success Rate

News

Two prominent preclinical safety companies have launched a unique European alliance to address the high safety-related failure rate in drug development.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE